WallStreetZenWallStreetZen

NASDAQ: MDRX
Veradigm Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

MDRX past earnings growth

How has MDRX's earnings growth performed historically?
Company
-90.85%
Industry
19.36%
Market
30.63%
MDRX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
MDRX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

MDRX past revenue growth

How has MDRX's revenue growth performed historically?
Company
3.88%
Industry
18.32%
Market
17.38%
MDRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MDRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MDRX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

MDRX earnings and revenue history

Current Revenue
$837.2M
Current Earnings
$60.6M
Current Profit Margin
7.2%
MDRX's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

MDRX Return on Equity

Current Company
4.7%
Current Industry
-18.3%
Current Market
-9.5%
MDRX's Return on Equity (4.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MDRX announces earnings.

MDRX Return on Assets

Current Company
2.9%
Current Industry
-4.9%
MDRX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MDRX Return on Capital Employed

Current Company
5.43%
Current Industry
-7.3%
MDRX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MDRX vs Health Information Service Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MDRX$837.19M$163.55M$60.63M-11.60%-84.91%
PHR$280.91M-$149.66M-$176.15M+28.61%N/A
NXGN$625.88M$75.10M$22.93M+3.47%+3.23%
DH$222.65M$42.10M-$6.04M+37.18%N/A
SDGR$180.96M-$137.49M-$149.19M+26.58%N/A
View Top Health Information Service Stocks

MDRX earnings dates

Next earnings date
May 3, 2023

Veradigm Earnings & Revenue FAQ

What were MDRX's earnings last quarter?

On Invalid Date, Veradigm (NASDAQ: MDRX) reported Q3 2022 earnings per share (EPS) of $0.13, up 0% year over year. Total Veradigm earnings for the quarter were $14.53 million. In the same quarter last year, Veradigm's earnings per share (EPS) was $0.13.

If you're new to stock investing, here's how to buy Veradigm stock.

What was MDRX's earnings growth in the past year?

As of Q1 2023, Veradigm's earnings has grown -90.85% year over year. This is 110.21 percentage points lower than the US Health Information Services industry earnings growth rate of 19.36%. Veradigm's earnings in the past year totalled $60.63 million.

What is MDRX's earnings date?

Veradigm's earnings date is Invalid Date. Add MDRX to your watchlist to be reminded of MDRX's next earnings announcement.

What was MDRX's revenue last quarter?

On Invalid Date, Veradigm (NASDAQ: MDRX) reported Q3 2022 revenue of $151.92 million up 5.01% year over year. In the same quarter last year, Veradigm's revenue was $144.67 million.

What was MDRX's revenue growth in the past year?

As of Q1 2023, Veradigm's revenue has grown 3.88% year over year. This is 14.45 percentage points lower than the US Health Information Services industry revenue growth rate of 18.32%. Veradigm's revenue in the past year totalled $837.19 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.